Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.836
Bid: 0.836
Ask: 0.842
Change: -0.002 (-0.24%)
Spread: 0.006 (0.718%)
Open: 0.838
High: 0.842
Low: 0.836
Prev. Close: 0.838
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

30 May 2023 15:08

RNS Number : 0607B
BioPharma Credit PLC
30 May 2023
 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

 

RESULT OF 2023 ANNUAL GENERAL MEETING

 

The Company is pleased to announce that, at the Annual General Meeting held today, all resolutions put to the meeting were passed by way of a poll.

 

 

Resolutions

Votes

For

%

Votes Against

%

Votes Withheld1

1: To receive and accept the annual report and financial statements

584,028,016

100.00%

0

0.00%

0

2: To approve the Directors' Remuneration Report

583,832,967

99.98%

132,056

0.02%

62,993

3: To re-elect Harry Hyman as a Director

509,140,483

87.18%

74,848,533

12.82%

39,000

4: To re-elect Colin Bond as a Director

583,961,133

100.00%

22,183

0.00%

44,700

5: To re-elect Duncan Budge as a Director

506,318,657

86.70%

77,664,659

13.30%

44,700

6: To re-elect Stephanie Léouzon as a Director

583,960,840

100.00%

22,476

0.00%

44,700

7: To re-elect Rolf Soderstrom as a Director

583,977,236

100.00%

6,080

0.00%

44,700

8: To elect Sapna Shah as a Director

583,973,133

100.00%

8,683

0.00%

46,200

9: To re-appoint Ernst & Young LLP as Auditor to the Company

572,909,389

98.10%

11,112,627

1.90%

6,000

10: To authorise the Directors to determine the remuneration of the Auditor

583,954,933

100.00%

20,060

0.00%

53,023

11: To approve the Company's dividend payment policy

573,028,016

98.12%

11,000,000

1.88%

0

12: To authorise the allotment of shares by the Company

582,922,005

100.00%

25,280

0.00%

1,080,731

13: To authorise the disapplication of pre-emption rights

556,590,025

95.48%

26,367,212

4.52%

1,070,779

14: To authorise the Company to make market purchases

of ordinary shares

509,047,631

87.32%

73,929,283

12.68%

1,051,102

15: To authorise the Company to hold general meetings

on 14 clear days' notice

583,949,781

99.99%

78,235

0.01%

0

 

1. A 'vote withheld' is not a vote under English law and is not counted in the calculation of votes 'for' or 'against' a resolution.

 

Copies of resolutions 12 to 15 have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

30 May 2023

 

 

Enquiries

 

BioPharma Credit plc

 

via Link Company Matters Limited

 

Company Secretary

 

T. +44 (0) 333 300 1950

 

Buchanan

 

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

 

+44 (0) 20 7466 5000

 

biopharmacredit@buchanan.uk.com

 

 

 

Notes to Editors:

 

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

 

 

 

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSDMFLSEDSESI
Date   Source Headline
29th Oct 20187:00 amRNSAdmission of Equity
24th Oct 20187:00 amRNSIncrease in Proposed Placing Size
19th Oct 20187:00 amRNSDividend Declaration
19th Oct 20187:00 amRNSNet Asset Value(s)
19th Oct 20187:00 amRNSPROPOSED PLACING OF ORDINARY SHARES
19th Oct 20187:00 amRNSConversion of C Shares
27th Sep 20187:00 amRNSHalf-year Report
21st Sep 20184:00 pmRNSNet Asset Value(s)
20th Sep 201811:38 amRNSUpdate on New Investment
20th Sep 20187:00 amRNSNew Investment
28th Aug 201811:20 amRNSNotice of Interim Results
21st Aug 20184:00 pmRNSNet Asset Value(s)
16th Aug 201812:45 pmRNSDividend Declaration
20th Jul 20184:00 pmRNSNet Asset Value(s)
18th Jul 20186:00 pmRNSDirector/PDMR Shareholding
2nd Jul 20187:00 amRNSUpdate on Investment
29th Jun 20184:47 pmRNSResult of AGM
21st Jun 20184:00 pmRNSNet Asset Value(s)
12th Jun 20184:00 pmRNSDirector/PDMR Shareholding
29th May 20184:10 pmRNSNotice of AGM
24th May 20182:00 pmRNSDividend Declaration
23rd May 20186:00 pmRNSHolding(s) in Company
22nd May 20184:00 pmRNSNet Asset Value(s)
4th May 201811:00 amRNSHolding(s) in Company
2nd May 201811:00 amRNSHolding(s) in Company
1st May 20182:30 pmRNSUpdate on New Investment
1st May 201810:15 amRNSTotal Voting Rights
26th Apr 20184:10 pmRNSDirector Declaration
23rd Apr 20185:00 pmRNSHolding(s) in Company
23rd Apr 20184:00 pmRNSNet Asset Value(s)
23rd Apr 20187:00 amRNSNew Investment
16th Apr 20186:00 pmRNSTotal Voting Rights
13th Apr 20187:00 amRNSResults of Initial Placing and Offer
11th Apr 201812:00 pmRNSResult of EGM
5th Apr 20186:00 pmRNSHolding(s) in Company - Correction
4th Apr 20186:00 pmRNSHolding(s) in Company
27th Mar 20185:30 pmRNSHolding(s) in Company
21st Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20184:00 pmRNSNet Asset Value(s)
16th Mar 20181:30 pmRNSPublication of Circular
14th Mar 20185:15 pmRNSHolding(s) in Company
14th Mar 201812:00 pmRNSPublication of a Prospectus
8th Mar 20187:05 amRNSProposed Issue of C Shares
8th Mar 20187:00 amRNSAnnual Financial Report
1st Mar 20186:00 pmRNSDividend Declaration
1st Mar 20187:00 amRNSNotice of Full Year Results
21st Feb 20184:00 pmRNSNet Asset Value(s)
15th Feb 20184:30 pmRNSHolding(s) in Company
8th Feb 20187:00 amRNSNew Investment
22nd Jan 20184:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.